Clinical trials recruiting in Wuhu, China

Phase breakdown

Conditions recruiting in Wuhu, China

Recruiting trials in Wuhu, China

• A Clinical Study of Neoadjuvant Treatment With TQB2102 for Injection for Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer
  NCT07043725 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female)
• A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus
  NCT07662109 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• A Phase III Trial of BNT324 Versus Docetaxel in Metastatic Castration-resistant Prostate Cancer
  NCT07365995 · Phase: Phase 3 · Ages: 18 Years and older · Sex: Male
• A Study of BBT001 in Healthy Volunteers (HVs) and in Adult Patients With Moderate to Severe Atopic Dermatitis (AD)
  NCT07239947 · Phase: Phase 1 · Ages: 18 Years to 65 Years · Sex: All (male and female)
• A Study of Brenipatide in Adult Participants With Schizophrenia
  NCT07410507 · Phase: Phase 2 · Ages: 18 Years to 55 Years · Sex: All (male and female)
• A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation
  NCT06952803 · Phase: Phase 3 · Ages: 18 Years and older · Sex: Male
• A Study of Vedolizumab in Adult Participants With Moderate to Severe Crohn's Disease
  NCT05837897 · Phase: Phase 3 · Ages: 18 Years to 80 Years · Sex: All (male and female)
• A Study to Investigate Efficacy and Safety of PT027 Compared With PT007 in Symptomatic Chinese Adults With Asthma
  NCT06471257 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• A Study to Investigate the Efficacy and Safety of Elecoglipron in Asian Participants With Obesity or Overweight With or Without Type 2 Diabetes Mellitus
  NCT07775404 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.
  NCT06629779 · Phase: Phase 3 · Ages: 18 Years and older · Sex: Male
• Assessment of the Efficacy and Safety of Fecal Microbiota Transplantation (FMT) in Patients With Major Depressive Disorder
  NCT06692361 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 65 Years · Sex: All (male and female)
• China HeadAche DIsorders RegiStry
  NCT05334927 · Phase: Not specified · Ages: 12 Years and older · Sex: All (male and female)
• China Health Big Data
  NCT03699228 · Phase: Not specified · Ages: 30 Years to 90 Years · Sex: All (male and female)
• Clinical Study of CEA Targeting Chimeric Antigen Receptor T Lymphocytes（CAR-T） for CEA Positive Advanced Malignant Solid Tumors
  NCT06126406 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female)
• Diagnostic Value of the Liver Inflammation Index for MASH in Patients With T2DM and MAFLD
  NCT07632677 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female)
• Efficacy, Safety, Pharmacokinetics of ICP-488 in Patients With Moderate to Severe Plaque Psoriasis
  NCT06842199 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female)
• Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation
  NCT05696626 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• Furmonertinib Monotherapy and Combination Therapy in Advanced EGFR Mutant NSCLC With Uncleared ctDNA
  NCT05334277 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female)
• ICP-332 in Subjects With Moderate to Severe Atopic Dermatitis
  NCT06775860 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female)
• Local Liver Treatment for Multi-organ Colorectal Cancer Metastases
  NCT06449937 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 80 Years · Sex: All (male and female)
• Pleth Variability Index for Predicting Low Blood Pressure During Maintenance Hemodialysis
  NCT07022847 · Phase: Not specified · Ages: 18 Years to 80 Years · Sex: All (male and female)
• Predictive Value of Carotid Ultrasonography for Intradialytic Hypotension
  NCT07033260 · Phase: Not specified · Ages: 18 Years to 80 Years · Sex: All (male and female)
• RC148 Plus Platinum-Based Chemotherapy vs Tislelizumab Plus Platinum-Based Chemotherapy for First-Line Squamous Non-Small Cell Lung Cancer (sqNSCLC)
  NCT07416474 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female)
• Study of MCLA-129, a Human Bispecific EGFR and cMet Antibody, in Patients With Advanced NSCLC and Other Solid Tumors
  NCT04930432 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female)
• The Addictive Diagnostic Value of Apparent Diffusion Coefficients to bpMRI in the Diagnosis of Prostate Cancer
  NCT06737588 · Phase: Not specified · Ages: 18 Years and older · Sex: Male
• The Clinical Trial of TQB2102 for Injection Against Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer
  NCT06452706 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female)
• This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
  NCT07028853 · Phase: Phase 3 · Ages: 18 Years and older · Sex: Male

Common questions

How many clinical trials are recruiting in Wuhu, China?

27 recruiting trials have at least one study site in Wuhu, China.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.